It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The recently developed droplet-based single-cell transcriptome sequencing (scRNA-seq) technology makes it feasible to perform a population-scale scRNA-seq study, in which the transcriptome is measured for tens of thousands of single cells from multiple individuals. Despite the advances of many clustering methods, there are few tailored methods for population-scale scRNA-seq studies. Here, we develop a Bayesian mixture model for single-cell sequencing (BAMM-SC) method to cluster scRNA-seq data from multiple individuals simultaneously. BAMM-SC takes raw count data as input and accounts for data heterogeneity and batch effect among multiple individuals in a unified Bayesian hierarchical model framework. Results from extensive simulation studies and applications of BAMM-SC to in-house experimental scRNA-seq datasets using blood, lung and skin cells from humans or mice demonstrate that BAMM-SC outperformed existing clustering methods with considerable improved clustering accuracy, particularly in the presence of heterogeneity among individuals.
With the development of large scale single cell RNA-seq technology, population-scale scRNA-seq studies are emerging. Here, the authors develop BAMM-SC, a tool for clustering droplet-based scRNA-seq data from multiple individuals simultaneously.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Chen, Kong 11 ; Ding, Ying 1 ; Hu, Ming 12
; Chen, Wei 13
1 University of Pittsburgh, Department of Biostatistics, Graduate School of Public Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
2 Harrison School of Pharmacy, Auburn University, Department of Health Outcomes Research and Policy, Auburn, USA (GRID:grid.252546.2) (ISNI:0000 0001 2297 8753)
3 Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, Division of Pulmonary Medicine, Department of Pediatrics, Pittsburgh, USA (GRID:grid.252546.2)
4 Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, Division of Pulmonary Medicine, Department of Pediatrics, Pittsburgh, USA (GRID:grid.252546.2); Tsinghua University, School of Medicine, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178)
5 University of Michigan, Department of Biostatistics, School of Public Health, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
6 University of Pittsburgh, Department of Immunology, School of Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
7 University of Pittsburgh, Division of Rheumatology and Clinical Immunology, Department of Medicine, School of Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
8 Tulane University, School of Medicine, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
9 University of Pittsburgh, Department of Immunology, School of Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); UPMC Hillman Cancer Center, Tumor Microenvironment Center, Pittsburgh, USA (GRID:grid.478063.e) (ISNI:0000 0004 0456 9819)
10 University of Pittsburgh, Department of Immunology, School of Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); UPMC Hillman Cancer Center, Tumor Microenvironment Center, Pittsburgh, USA (GRID:grid.478063.e) (ISNI:0000 0004 0456 9819); UPMC Hillman Cancer Center, Cancer Immunology and Immunotherapy Program, Pittsburgh, USA (GRID:grid.478063.e) (ISNI:0000 0004 0456 9819)
11 University of Pittsburgh, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, School of Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
12 Lerner Research Institute, Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725)
13 University of Pittsburgh, Department of Biostatistics, Graduate School of Public Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, Division of Pulmonary Medicine, Department of Pediatrics, Pittsburgh, USA (GRID:grid.21925.3d)




